Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Free Report) has received an average recommendation of “Reduce” from the eight research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and seven have issued a hold recommendation on the company. The average 1 year target […]
HC Wainwright reaffirmed their neutral rating on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $1.50 target price on the stock. Reneo Pharmaceuticals Trading Up 5.4 % Shares of RPHM stock opened at $1.75 on Tuesday. The stock has a […]
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Acquires 414,281 Shares of Stock dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of Reneo Pharmaceuticals, Inc. and OnKure, Inc..
RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.